| ［1］ Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of targeted magnetic nanoparticles［J］. Trends Biotechnol, 2011, 29(7): 323332.
［2］ Thomas R, Park IK, Jeong YY. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer［J］. Int J Mol Sci, 2013, 14(8): 1591015930.
［3］ TorayaBrown S, Sheen MR, Baird JR, et al. Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy［J］. Integr Bio(Camb), 2013, 5(1):159171.
［4］ MaierHauff K, Ulrich F, Nestler D, et al. Efficacy and safety of intratumoral thermotherapy using magnetic ironoxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme ［J］. J Neurooncol, 2011, 103(2):317324.
［5］ Estevanato L, Cintra D, Baldini N, et al. Preliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery system ［J］. Int J Nanomedicine, 2011, 6:17091717.
［6］ Gao H, Jiang X. Progress on the diagnosis and evaluation of brain tumors［J］. Cancer Imaging, 2013, 13(4):466481.
［7］ Ludwig R, Stapf M, Dutz S, et al. Structural properties of magnetic nanoparticles determine their heating behavior an estimation of the in vivo heating potential［J］. Nanoscale Res Lett, 2014, 9(1):602.
［8］ Fourmy D, Carrey J, Gigoux V. Targeted nanoscale magnetic hyperthermia: challenges and potentials of peptidebasedtargeting［J］. Nanomedicine (Lond), 2015, 10(6):893896.
［9］ MarcosCampos I, Asín L, Torres TE, et al. Cell death induced by the application of alternating magnetic fields to nanoparticleloaded dendritic cells. Nanotechnology［J］. 2011, 22(20): 205101.
［10］ RodríguezLuccioni HL, LatorreEsteves M, MéndezVega J, et al. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles ［J］. Int J Nanomedicine, 2011, 6:373380.
［11］ Guardia P, Di Corato R, Lartigue L, et al. Watersoluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment ［J］. ACS Nano, 2012, 6(4): 30803091.
［12］ Bae KH, Park M, Do MJ, et al. Chitosan oligosaccharidestabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia ［J］. ACS Nano, 2012, 6(6): 52665273.
［13］ Lee JH, Jang JT, Choi JS, et al. Exchangecoupled magnetic nanoparticles for efficient heat induction［J］. Nat Nanotechnol, 2011, 6(7): 418422.
［14］ Noh SH, Na W, Jang JT, et al. Nanoscale magnetism control via surface and exchange anisotropy for optimized ferrimagnetic hysteresis ［J］. Nano Lett, 2012, 12(7):37163721.
［15］ Mahmoudi K, Hadjipanayis CG. The application of magnetic nanoparticles for the treatment of brain tumors ［J］. Front Chem, 2014, 2: 109.
［16］ Salunkhe AB, Khot VM, Pawar SH. Magnetic Hyperthermia with Magnetic Nanoparticles: A Status Review［J］. Curr Top Med Chem, 2014,14(5): 572594.
［17］ van Landeghem FK, MaierHauff K, Jordan A, et al. Postmortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles［J］. Biomaterials， 2009， 30(1): 5257.
［18］ MaierHauff K, Ulrich F, Nestler D, et al. Efficacy and safety of intratumoral thermotherapy using magnetic ironoxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme［J］. J Neurooncol, 2011, 103(2):317324.
［19］ Alphandéry E. Perspectives of breast cancer thermotherapies［J］. J Cancer, 5(6): 472479.
［20］ Oliveira TR, Stauffer PR, Lee CT. Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study ［J］. Int J Hyperthermia, 2013, 29(8): 835844.
［21］ 尹燕鹰， 顾宁， 洪敏, 等. 靶向磁性热疗对小鼠结肠癌皮下移植模型作用的观察［J］. 中华肿瘤防治杂志， 2013, 20（4）:249253.
［22］ Dutz S, Hergt R. Magnetic particle hyperthermia—a promising tumor therapy? ［J］. Nanotechnology, 2014, 25(45): 452001. |
